ID
30203
Beschrijving
Study ID: 108414 Clinical Study ID: DBU108414 Study Title: TXA107979: A placebo-controlled, single blind, randomized two part study to investigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01036061 https://clinicaltrials.gov/ct2/show/NCT01036061 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK618334 Study Indication: Substance Dependence Documentation part: Pharmacokinetics Urine
Link
https://clinicaltrials.gov/ct2/show/NCT01036061
Trefwoorden
Versies (1)
- 18-05-18 18-05-18 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
18 mei 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Tolerability, pharmacokinetics, and brain Dopamine D3 receptor occupancy of increasing repeat doses of GSK618334 in healthy adults NCT01036061
Pharmacokinetics Urine
- StudyEvent: ODM
Similar models
Pharmacokinetics Urine
- StudyEvent: ODM
C0042036 (UMLS CUI-2)
C0022885 (UMLS CUI-3)
C0031328 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,3])
C0200354 (UMLS CUI [1,2])